The Secret in Cytokinin Technology

Leave a Comment

pyratine (133x200)

 

Cytokinin Technology has been mentioned on our website time and time again. Listed as furfuryl tetrahydropyranyladenine in the ingredient deck, it’s not just one of the components that makes PyratineXR® great, it’s the distinguishing feature.  However, with all this talk about cytokinins many people are still left wondering, “What is it?”

 

Cytokinins are growth factors found in the DNA of most plants. They aid in cell growth, prevent protein breakdown and slow down the aging process for most living organisms. When in contact with another growth factor called auxin, it helps regulate cell division, grow buds and form roots.

 

Called by its technical name as furfuryl tetrahydropyranyladenine,  PyratineXR® is a second generation cytokinin with significant advances over Kinetin.  Kinetin was originally isolated in 1955 by Dr. Carlos Miller in the lab of Dr. Folke K. Skoog at the University of Wisconsin-Madison. It was soon used to regenerate plant tissue in farming and botany.

 

In 1994 a radical study by Dr. Suresh Rattan and Dr. Brian F.C. Clark at the University of Aarhus in Denmark was published. The doctors found that cytokinins like kinetin acted as natural antioxidants which stimulated DNA repair and delayed human age related changes to fibroblasts (the most common connective tissue cells found in humans). Since then, hundreds more studies have been published by researchers touting the benefits of kinetin and advancing cytokinin technology for human application.

 

We utilize cytokinin technology in PyratineXR® by formulating  0.125% furfuryl tetrahydropyranyladenine in a soothing topical moisturizer. The moisturizer acts as a protective barrier as the cytokinin is directly absorbed in areas of the skin that need it the most. With studies showing 80% improvement in reducing redness, lesions and spider veins associated with rosacea from PyratineXR® usage, it’s no wonder the secret in PyratineXR® is quite special and revolutionary.

Comments are closed